CereMark Pharma LLC

Focused on a future for better detection of neurodegenerative impairment.

[CereMark Pharma LLC @ceremark]

Congrats to Cherie Strikwerda-Brown et al on recent findings reported in JAMA Neurology of clinical significance of PET biomarker scanning for beta amyloid plaque and tau aggregates in four different independent population-based cohorts (PEVENT-AD, HABS, AIBL, and Knight ADRC).